Pharmaceutical Excipients Market Growing at 7.6% CAGR during 2025
Pune, Maharashtra, India, February 10 2021 (Wiredrelease) Allied Analytics –:Allied Market Research published a report, titled, “Pharmaceuticals Excipients Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $6.4 billion by 2025, registering a CAGR of 7.6% during the period 2020-2025. Organic chemicals would continue to be the highest revenue-generating segment during the forecast period.
North America accounted for about one third of the overall market revenue in 2015 owing to the presence of a large number of pharmaceutical companies.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/1053
• Due to the global pandemic all over the world, the medical devices manufacturers are majorly focusing on essential medical devices production including ventilators and diagnostics.
• However, due to the precautionary measures taken by governments in various regions, the supply chain has been hampered. Which may result in shortage of devices in certain locations.
• Food and Drugs Administration (FDA), on the other hand, shared a COVID-19 guidance with medical device manufacturers to notify the agency about changes that could affect availability of their products.
Binders segment generated highest revenue in 2015 and is anticipated to maintain this trend throughout the forecast period. This is attributed to the higher use of binders in pharmaceutical drugs as compared to fillers and diluents. However, fillers and diluents led this segment in terms of volume (units) in 2015 and accounted for about one fourth of the overall market. Economical cost and high popularity of fillers and diluents across pharmaceutical and excipient industries were the key factors responsible for the dominance of filler and diluents segment.
Factors that drive the global pharmaceutical excipients market are rising demand for pharmaceutical drugs, increasing popularity of functional excipients, drug pipeline, development of novel excipients, and increasing generic drugs market caused by expiration of various bestseller drugs patents. Factors that are likely to impede the market growth include, supply chain issues, high market fragmentation, and implementation of stringent regulations.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/1053
Key findings of Pharmaceutical Excipients Market:
Binders generated the highest revenue accounting for about two-seventh of the overall market revenue in 2015.
In the inorganic chemical category, halites segment is projected to grow at the highest CAGR of 29.2% during the forecast period.
Calcium phosphate (inorganic chemical) segment is projected to reach $539.9 million by 2025 at a CAGR of 10.5%.
In the organic chemicals category, carbohydrates generated the highest revenue and is expected to dominate till 2020.Disintegrates segment is projected to grow at a highest CAGR of 12.6% from 2015 to 2025.
Proteins segment (Petrochemicals category) generated highest revenue in 2015; however, mineral hydrocarbons segment is expected to grow at the highest CAGR of 7.0% during the period under consideration.
North America accounted for about one third of the overall market revenue in 2015 owing to the presence of large number of pharmaceutical companies. The pharmaceutical excipients market in the developing economies has lucrative growth opportunities due to the availability of inexpensive raw materials and economical workforce. The global pharmaceutical excipient manufacturers are relocating to the developing economies by adopting strategies such as, agreement & acquisition with the local players. Moreover, lack of stringent regulations for the production of excipients also supports its growth in the developing economies.
To know more about the report, visit the website at: https://www.alliedmarketresearch.com/pharmaceutical-excipients-market
The key companies included in the report are Ashland, Inc., BASF SE, Associated British Foods Plc, Akzo Nobel N.V., The Dow Chemical Company, Evonik, Merck, J.M. Huber Corporation, Covidien Plc, and Archer Daniels Midland.
Similar Reports With COVID-19 Impact:
Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This content has been published by Allied Analytics company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at email@example.com.